Which of the following describes a moderate-intensity statin dose according to current guidelines?

Which of the following describes a moderate-intensity statin dose according to current guidelines?

• A. Pravastatin 20 mg/day
• B. Rosuvastatin 10 mg/day
• C. Atorvastatin 40 mg/day
• D. Lipitor 20 mg/day

Answer: (B)

The answer of Rosuvastatin 10 mg/day as a moderate-intensity statin dose aligns with the current cholesterol treatment guidelines established by major health organizations. Moderate-intensity statins are defined as doses that lower low-density lipoprotein (LDL) cholesterol levels by approximately 30% to 49%. Rosuvastatin at 10 mg is recognized as a moderate-intensity dose because it effectively reduces LDL cholesterol within that target range. According to the American College of Cardiology/American Heart Association (ACC/AHA) guidelines, this specific dosage achieves the moderate-intensity threshold, making it suitable for patients who require LDL cholesterol lowering without the need for high-intensity statin therapy. In contrast, while Pravastatin 20 mg/day, Atorvastatin 40 mg/day, and Lipitor 20 mg/day are mentioned, they represent different dosing categories. Pravastatin at 20 mg is considered a low-intensity statin dose, Atorvastatin 40 mg/day is generally classified as a high-intensity dose, and Lipitor, known as the brand name for Atorvastatin, does not differentiate in terms of dose classification. Understanding these classifications is crucial for appropriately managing cholesterol levels and

The answer of Rosuvastatin 10 mg/day as a moderate-intensity statin dose aligns with the current cholesterol treatment guidelines established by major health organizations. Moderate-intensity statins are defined as doses that lower low-density lipoprotein (LDL) cholesterol levels by approximately 30% to 49%.

Rosuvastatin at 10 mg is recognized as a moderate-intensity dose because it effectively reduces LDL cholesterol within that target range. According to the American College of Cardiology/American Heart Association (ACC/AHA) guidelines, this specific dosage achieves the moderate-intensity threshold, making it suitable for patients who require LDL cholesterol lowering without the need for high-intensity statin therapy.

In contrast, while Pravastatin 20 mg/day, Atorvastatin 40 mg/day, and Lipitor 20 mg/day are mentioned, they represent different dosing categories. Pravastatin at 20 mg is considered a low-intensity statin dose, Atorvastatin 40 mg/day is generally classified as a high-intensity dose, and Lipitor, known as the brand name for Atorvastatin, does not differentiate in terms of dose classification.

Understanding these classifications is crucial for appropriately managing cholesterol levels and